EGFR and prostate cancer: Downregulated mRNAs were mainly enriched in prostate cancer, transcriptional misregulation in cancer, melanoma, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, and microRNAs in cancer (Supplement Table 4) (Figure 2).